Jean-Francois Fortin, Ph.D. - Publications

Affiliations: 
2000 Universite Laval (Canada) 
Area:
Microbiology Biology, Immunology

19 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2009 Tardif MR, Gilbert C, Thibault S, Fortin JF, Tremblay MJ. LFA-1 antagonists as agents limiting human immunodeficiency virus type 1 infection and transmission and potentiating the effect of the fusion inhibitor T-20. Antimicrobial Agents and Chemotherapy. 53: 4656-66. PMID 19721069 DOI: 10.1128/Aac.00117-09  0.61
2007 Zampieri CA, Fortin JF, Nolan GP, Nabel GJ. The ERK mitogen-activated protein kinase pathway contributes to Ebola virus glycoprotein-induced cytotoxicity. Journal of Virology. 81: 1230-40. PMID 17108034 DOI: 10.1128/Jvi.01586-06  0.361
2005 Schaap A, Fortin JF, Sommer M, Zerboni L, Stamatis S, Ku CC, Nolan GP, Arvin AM. T-cell tropism and the role of ORF66 protein in pathogenesis of varicella-zoster virus infection. Journal of Virology. 79: 12921-33. PMID 16188994 DOI: 10.1128/Jvi.79.20.12921-12933.2005  0.401
2004 Fortin JF, Barat C, Beauséjour Y, Barbeau B, Tremblay MJ. Hyper-responsiveness to stimulation of human immunodeficiency virus-infected CD4+ T cells requires Nef and Tat virus gene products and results from higher NFAT, NF-kappaB, and AP-1 induction. The Journal of Biological Chemistry. 279: 39520-31. PMID 15258149 DOI: 10.1074/Jbc.M407477200  0.672
2003 Losier M, Fortin JF, Cantin R, Bergeron MG, Tremblay MJ. Virion-bound ICAM-1 and activated LFA-1: a combination of factors conferring resistance to neutralization by sera from human immunodeficiency virus type 1-infected individuals independently of the disease status and phase. Clinical Immunology (Orlando, Fla.). 108: 111-8. PMID 12921757 DOI: 10.1016/S1521-6616(03)00093-7  0.622
2002 Roy J, Paquette JS, Fortin JF, Tremblay MJ. The immunosuppressant rapamycin represses human immunodeficiency virus type 1 replication. Antimicrobial Agents and Chemotherapy. 46: 3447-55. PMID 12384349 DOI: 10.1128/Aac.46.11.3447-3455.2002  0.65
2002 Robichaud GA, Barbeau B, Fortin JF, Rothstein DM, Tremblay MJ. Nuclear factor of activated T cells is a driving force for preferential productive HIV-1 infection of CD45RO-expressing CD4+ T cells. The Journal of Biological Chemistry. 277: 23733-41. PMID 11956207 DOI: 10.1074/Jbc.M201563200  0.735
2001 Barbeau B, Robichaud GA, Fortin JF, Tremblay MJ. Negative regulation of the NFAT1 factor by CD45: implication in HIV-1 long terminal repeat activation. Journal of Immunology (Baltimore, Md. : 1950). 167: 2700-13. PMID 11509614 DOI: 10.4049/Jimmunol.167.5.2700  0.723
2001 Fortin JF, Barbeau B, Robichaud GA, Paré ME, Lemieux AM, Tremblay MJ. Regulation of nuclear factor of activated T cells by phosphotyrosyl-specific phosphatase activity: a positive effect on HIV-1 long terminal repeat-driven transcription and a possible implication of SHP-1. Blood. 97: 2390-400. PMID 11290602 DOI: 10.1182/Blood.V97.8.2390  0.723
2001 Fortin J, Cantin R, Tremblay M. Présence des protéines de la cellule hôte sur les particules virales : influences sur le cycle de vie du VIH-1. MéDecine/Sciences. 17: 186. DOI: 10.4267/10608/1891  0.472
2000 Fortin JF, Cantin R, Bergeron MG, Tremblay MJ. Interaction between virion-bound host intercellular adhesion molecule-1 and the high-affinity state of lymphocyte function-associated antigen-1 on target cells renders R5 and X4 isolates of human immunodeficiency virus type 1 more refractory to neutralization. Virology. 268: 493-503. PMID 10704357 DOI: 10.1006/Viro.2000.0190  0.656
1999 Fortin JF, Barbeau B, Hedman H, Lundgren E, Tremblay MJ. Role of the leukocyte function antigen-1 conformational state in the process of human immunodeficiency virus type 1-mediated syncytium formation and virus infection. Virology. 257: 228-38. PMID 10208936 DOI: 10.1006/Viro.1999.9687  0.643
1999 Fortin JF, Barbeau B, Robichaud CA, Tremblay MJ. T cell activation and regulation of HIV-1: Same effectors with distinct outcomes Canadian Journal of Infectious Diseases. 10. DOI: 10.1155/1999/717641  0.641
1998 Paquette JS, Fortin JF, Blanchard L, Tremblay MJ. Level of ICAM-1 surface expression on virus producer cells influences both the amount of virion-bound host ICAM-1 and human immunodeficiency virus type 1 infectivity. Journal of Virology. 72: 9329-36. PMID 9765484 DOI: 10.1128/Jvi.72.11.9329-9336.1998  0.648
1998 Tremblay MJ, Fortin JF, Cantin R. The acquisition of host-encoded proteins by nascent HIV-1. Immunology Today. 19: 346-51. PMID 9709501 DOI: 10.1016/S0167-5699(98)01286-9  0.626
1998 Barbeau B, Fortin JF, Genois N, Tremblay MJ. Modulation of human immunodeficiency virus type 1-induced syncytium formation by the conformational state of LFA-1 determined by a new luciferase-based syncytium quantitative assay. Journal of Virology. 72: 7125-36. PMID 9696806 DOI: 10.1128/Jvi.72.9.7125-7136.1998  0.652
1998 Fortin JF, Cantin R, Tremblay MJ. T cells expressing activated LFA-1 are more susceptible to infection with human immunodeficiency virus type 1 particles bearing host-encoded ICAM-1. Journal of Virology. 72: 2105-12. PMID 9499066 DOI: 10.1128/Jvi.72.3.2105-2112.1998  0.664
1997 Cantin R, Fortin J, Lamontagne G, Tremblay M. The Acquisition of Host-Derived Major Histocompatibility Complex Class II Glycoproteins by Human Immunodeficiency Virus Type 1 Accelerates the Process of Virus Entry and Infection in Human T-Lymphoid Cells Blood. 90: 1091-1100. DOI: 10.1182/Blood.V90.3.1091.1091_1091_1100  0.637
1996 Cantin R, Fortin JF, Tremblay M. The amount of host HLA-DR proteins acquired by HIV-1 is virus strain- and cell type-specific. Virology. 218: 372-81. PMID 8610464 DOI: 10.1006/Viro.1996.0206  0.623
Show low-probability matches.